Govt may review FDI policy in pharma, housing tomorrow

Last Updated: Wednesday, November 27, 2013, 18:54

The Cabinet is likely to take a decision Thursday on relaxing FDI norms for the housing sector and reducing foreign investment limit to 49 percent in rare and critical areas of the pharma segment.

Cabinet likely to decide on FDI in pharma, housing today

Last Updated: Monday, November 25, 2013, 09:22

With serious concerns being raised from various departments regarding the acquisition of Indian drug firms by global multinational entities, the government is likely to consider reducing the foreign direct investment cap in the pharma sector.

Govt to review FDI policy in pharma sector on Monday

Last Updated: Friday, November 22, 2013, 20:20

Government will take up on Monday the issue of tightening FDI in existing pharmaceutical companies in the wake of concerns over multinationals taking over domestic drug makers.

New drug policy, regulations slowing down pharma growth: Report

Last Updated: Thursday, October 31, 2013, 15:14

Growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 percent in 2013 as compared to 16.6 percent in 2012, says a report.

Hiring grows by 24% in recession-proof pharma sector

Last Updated: Sunday, October 27, 2013, 10:57

Amid continuing business expansion, hiring in India's pharmaceutical sector grew an estimated 24 percent in the current financial year and job creation may continue in the near future.

Unfair practices in pharma sector under CCI scanner

Last Updated: Wednesday, October 2, 2013, 13:34

Emphasising that pricing aspects of pharmaceuticals are critical for the general public, CCI Chairman Ashok Chawla has said that some cases of probe into alleged unfair practices in this space are in the "pipeline".

Indian pharma draws more scrutiny as US exports rise

Last Updated: Sunday, September 15, 2013, 08:59

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories, face closer FDA scrutiny as the agency ramps up its presence in the country.

FDI in pharma: DIPP to circulate draft cabinet note this week

Last Updated: Tuesday, August 20, 2013, 18:11

The Department of Industrial Policy and Promotion is expected to circulate a draft cabinet note this week proposing major changes in FDI policy for existing pharma companies to protect domestic generic firms.

FDI policy in pharma set for major overhaul

Last Updated: Friday, August 16, 2013, 17:57

The government is set to make major changes in the current FDI policy in the pharmaceuticals sector to protect domestic generic industry in the wake of increasing acquisitions of homegrown companies by foreign players.

Govt to soon finalise FDI policy on pharma sector

Last Updated: Monday, August 12, 2013, 22:08

Finance Minister P Chidambaram on Monday said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects, paving the way for clearance of held-up proposals.

US to hike fees for generic drugmakers; Indian firms to be hit

Last Updated: Sunday, August 11, 2013, 12:27

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October.

FIPB clears 6 pharma proposals worth Rs 855 cr

Last Updated: Monday, July 29, 2013, 23:18

The Foreign Investment Promotion Board (FIPB) Monday cleared six proposals envisaging investments of Rs 855 crore in the pharmaceutical sector, including one by Fresenius Kabi.